Sophia N Karagiannis, Professor of Translational Cancer Immunology and Immunotherapy at King’s College London, shared a post on LinkedIn:
“We are grateful to have received funding from Wellbeing of Women to develop new antibody immunotherapies for the treatment of ovarian cancer.
Together with Alicia Chenoweth, expert in antibody science, Debra Josephs, Consultant Medical Oncologist experienced in bringing novel antibody immunotherapy research to the clinic, and Dr Rebecca Kristeleit, Consultant Medical Oncologist specialising in gynecologic oncology clinical trials at King’s Faculty of Life Sciences and Medicine, King’s College London and Guy’s and St Thomas’ NHS Foundation Trust, we are striving to break new ground in the design of novel antibody therapies to harness and activate the patient’s immune cells against ovarian cancer.
We look forward to working with our highly dedicated colleagues at Wellbeing of Women with the vision to bring new technologies to patients as efficiently as possible.”
More posts about Ovarian cancer.